VERU INC. Accounts Payable and Other Accrued Liabilities, Current
VERU INC. (VERU) had Accounts Payable and Other Accrued Liabilities, Current of $949.09 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable and Other Accrued Liabilities, Current $949.09K.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities, Current $382.88K.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $300.35K.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $394.53K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $949.09K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $382.88K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $300.35K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $394.53K 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $378.69K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $482.18K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $535.47K 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $669.68K 10-K · filed 2025-12-17 | $2.06M 10-K · filed 2024-12-16 |
| 2024-06-30 | $2.19M 10-Q · filed 2024-08-08 | |
| 2023-09-30 | $1.99M 10-K · filed 2024-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |